Portfolio Diversification Strategy
Hayek Kallen Investment Management discloses new second-quarter stakes in major corporations.
Anonymous
Key Points
1
Parker-Hannifin paid a quarterly dividend of $2.00 per share (about $8.00 annualized) with a yield of ~0.8% and an ex-dividend date of August 31, details that accompany Hayek Kallen’s new 725-share stake in Q2.
2
Parker-Hannifin’s stock data around the period shows it opened at $1,010.69, with a 50-day moving average of $990.89 and a 200-day moving average of $950.16; the stock carries a P/E of 35.48, a PEG of 2.71, and a beta of 1.12, with a 12-month range of $715.37–$1,099.94 and a market cap near $127.4 billion.
3
Bank of New York Mellon (BNY) shows heavy institutional ownership at about 85.31%, and the stock has recent analyst activity including Erste Group initiating coverage with a Buy rating and Wells Fargo raising its price target to $162.
4
Automatic Data Processing (ADP) entry includes Hayek Kallen purchasing 2,550 shares for roughly $571,000, with overall institutional ownership in ADP around 80.03% and other hedge funds increasing positions (e.g., SBI Securities, Nordwand Advisors, Cary Street Partners, Guardian Partners, Reston Wealth Management).
5
Merck KGaA (MKGA.F or MKGAF) saw Hayek Kallen acquire 24,059 shares valued at about $3.09 million, a holding amid very low institutional ownership of roughly 0.10%, with other new stakes held by ADAR1 Capital Management, Barrow Hanley Mewhinney & Strauss, Whalen Wealth Management, CIBC World Market, and Madison Wealth Partners.
Hayek Kallen Investment Management expanded its portfolio in the second quarter with new stakes across industrials, finance, and business services. The firm bought 725 shares of Parker-Hannifin for about $709,000, 6,429 shares of Bank of New York Mellon for roughly $930,000, and 2,550 shares of Automatic Data Processing for approximately $571,000, according to Watchlist News. A larger position in Merck KGaA rounded out the moves, with Hayek Kallen acquiring 24,059 shares valued near $3.09 million.
Parker-Hannifin Attracts Institutional Investment
Parker-Hannifin remains a favorite among large investors, with institutional holders controlling about 82.44% of the stock. The industrial company trades at a P/E ratio of 35.48 and carries a beta of 1.12, showing moderate volatility. During the period, the stock moved in a 50-day range around $990.89 and holds a 12-month trading window of $715.37 to $1,099.94.
Bank of New York Mellon Signals Strong Analyst Momentum
Bank of New York Mellon also drew Hayek Kallen's attention in Q2, with the purchase of 6,429 shares worth $930,000, according to Watchlist News. The bank shows deep institutional roots, with about 85.31% owned by large investors. Recent analyst moves bolster the stock's appeal: Erste Group initiated coverage with a Buy rating, while Wells Fargo raised its price target to $162.
ADP Entry Joins Wave of Hedge Fund Activity
Automatic Data Processing attracted Hayek Kallen's 2,550-share purchase for about $571,000 in Q2, Watchlist News reported. The business services provider enjoys broad institutional backing, with about 80.03% of shares held by large investors. Other hedge funds and wealth managers — including SBI Securities, Nordwand Advisors, Cary Street Partners, Guardian Partners, and Reston Wealth Management — also increased their ADP stakes during the period.
Merck KGaA Positions Offer Low Institutional Saturation
Hayek Kallen's largest Q2 purchase was Merck KGaA, buying 24,059 shares for roughly $3.09 million. Unlike its other new holdings, Merck KGaA shows very low institutional ownership at just 0.10%, creating room for long-term investors to build stakes. New positions from ADAR1 Capital Management, Barrow Hanley Mewhinney & Strauss, Whalen Wealth Management, CIBC World Markets, and Madison Wealth Partners signal growing interest in the German chemicals and pharma company.
Sentiment
Mostly PositiveNEGATIVENEUTRALPOSITIVE
Publishers
14
Articles
25
Reach
39
A
AnonymousAuthor
